Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Plos One|April 8, 2016
Spatio-Temporal Patterns of Demyelination and Remyelination in the Cuprizone Mouse ModelIan Tagge, Audrey O'Connor, Priya Chaudhary, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 14, 2008
The magnetic resonance shutter speed discriminates vascular properties of malignant and benign breast tumors in vivoWei Huang, Xin Li, Elizabeth A Morris, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 15, 2008
Dynamic NMR effects in breast cancer dynamic-contrast-enhanced MRIXin Li, Wei Huang, Elizabeth A Morris, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|March 10, 2026
Quantitative Choroid Plexus Gadolinium Enhancement Is Related to Diffuse Brain Tissue Injury in Multiple SclerosisSneha Senthil, Ian Tagge, Dumitru Fetco, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 7, 2017
The NAIMS cooperative pilot project: Design, implementation and future directionsJiwon Oh, Rohit Bakshi, Peter A Calabresi, et al.
Annals of Clinical and Translational Neurology|January 13, 2021
Myelin-specific T cells in animals with Japanese macaque encephalomyelitisAparna N Govindan, Kristin S Fitzpatrick, Minsha Manoharan, et al.
Journal of Neuroimmunology|February 10, 2016
Immunopathology of Japanese macaque encephalomyelitis is similar to multiple sclerosisTiffany C Blair, Minsha Manoharan, Stephanie D Rawlings-Rhea, et al.
Journal of Magnetic Resonance Imaging : JMRI|January 18, 2019
Multisite reliability and repeatability of an advanced brain MRI protocolDaniel L Schwartz, Ian Tagge, Katherine Powers, et al.
Magnetic Resonance in Medicine|June 16, 2017
Gradient nonlinearity effects on upper cervical spinal cord area measurement from 3D T1 -weighted brain MRI acquisitionsNico Papinutto, Rohit Bakshi, Antje Bischof, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 27, 2025
Safety and efficacy of opicinumab in participants with relapsing multiple sclerosis (AFFINITY Part 1): A randomized, controlled, phase 2 trialPeter A Calabresi, Gavin Giovannoni, Hans-Peter Hartung, et al.
Pageof 2